Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pill to beat jet lag? supplement fitoavia put to the test

NCT ID NCT07695870

Symptom relief Sponsor: MiraxBioPharma Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This study tests whether the dietary supplement Fitoavia can help people recover from jet lag faster. Adults who have traveled across at least four time zones will take either Fitoavia or a placebo for several days. Researchers will track symptoms like sleep disruption and thinking ability to see if the supplement speeds up normal body clock adjustment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Fitoavia (dietary supplement)
What this could lead to
If it works, this could offer a natural option to reduce jet lag symptoms and speed up adjustment to new time zones.
What could go wrong
This is a small, early-stage trial with a dietary supplement, so results may not be conclusive or generalizable. Supplements are not strictly regulated like drugs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

120 people

The number who actually took part.

Started

Oct 2025

Finished

Apr 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * • Voluntarily and personally signed informed consent form to participate in the study, before any of the research procedures. * Men and women over 18 years of age who have a time difference of more than four hours from their place of primary residence; * Confirmed flight in less than 24 hours * Previous adaptation to the new regimen for 3 or more days according to the screening questionnaire * Presence of three or more symptoms of jet lag on the screening questionnaire with a score above 5 Exclusion Criteria: * • Currently taking adaptogens

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognition improvement are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

circadian rhythm sleep disorder, jet lag type Jet Lag Syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cognition improvement Jet lag Jet lag disorder Jet lag type insomnia

Contacts and locations

Locations

  • MiraxBioPharma

    Moscow, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.